Skip to main content
Top
Published in: Critical Care 1/2020

Open Access 01-12-2020 | Infliximab | Research Letter

Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure—a cautionary case series

Authors: Andreas Stallmach, Andreas Kortgen, Falk Gonnert, Sina M. Coldewey, Philipp Reuken, Michael Bauer

Published in: Critical Care | Issue 1/2020

Login to get access

Excerpt

The severe acute respiratory coronavirus 2 (SARS-CoV-2) pandemic has prompted search for therapeutics tackling both the pathogen and the overwhelming host response, on an unprecedented scale. In a minority of patients, the disease may cause frequently lethal complications from acute respiratory distress syndrome to multisystem organ failure presumably driven by a cytokine storm [1]. Therefore, anti-cytokine therapies may be helpful to prevent tissue injury. However, these anti-inflammatory drugs constitute double-edged swords; while they can prevent organ damage, they increase the risk of concomitant (super)infection. …
Literature
2.
go back to reference Neurath MF. Covid-19 and immunomodulation in IBD. Gut. 2020.. Neurath MF. Covid-19 and immunomodulation in IBD. Gut. 2020..
3.
go back to reference Liu J, Li S, Liu J, Liang B, Wang X, Wang H, et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine. 2020;55:102763.CrossRef Liu J, Li S, Liu J, Liang B, Wang X, Wang H, et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine. 2020;55:102763.CrossRef
Metadata
Title
Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure—a cautionary case series
Authors
Andreas Stallmach
Andreas Kortgen
Falk Gonnert
Sina M. Coldewey
Philipp Reuken
Michael Bauer
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2020
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-020-03158-0

Other articles of this Issue 1/2020

Critical Care 1/2020 Go to the issue